255 related articles for article (PubMed ID: 30453886)
1. Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola.
Nasution MAF; Toepak EP; Alkaff AH; Tambunan USF
BMC Bioinformatics; 2018 Nov; 19(Suppl 14):419. PubMed ID: 30453886
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of Ebola nucleocapsid stability from molecular dynamics simulations.
Xu C; Katyal N; Nesterova T; Perilla JR
J Chem Phys; 2020 Oct; 153(15):155102. PubMed ID: 33092380
[TBL] [Abstract][Full Text] [Related]
4. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis.
Tambunan USF; Alkaff AH; Nasution MAF; Parikesit AA; Kerami D
J Mol Graph Model; 2017 Jun; 74():366-378. PubMed ID: 28482272
[TBL] [Abstract][Full Text] [Related]
5. Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring.
Onawole AT; Kolapo TU; Sulaiman KO; Adegoke RO
Comput Biol Chem; 2018 Feb; 72():170-180. PubMed ID: 29361403
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors.
Sulaiman KO; Kolapo TU; Onawole AT; Islam MA; Adegoke RO; Badmus SO
J Biomol Struct Dyn; 2019 Aug; 37(12):3029-3040. PubMed ID: 30058446
[TBL] [Abstract][Full Text] [Related]
7. Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolution.
Dong S; Yang P; Li G; Liu B; Wang W; Liu X; Xia B; Yang C; Lou Z; Guo Y; Rao Z
Protein Cell; 2015 May; 6(5):351-62. PubMed ID: 25910597
[TBL] [Abstract][Full Text] [Related]
8. Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40.
Mirza MU; Ikram N
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792169
[TBL] [Abstract][Full Text] [Related]
9. Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virus.
Kadam A; Sasidharan S; Saudagar P
Infect Genet Evol; 2020 Nov; 85():104464. PubMed ID: 32681997
[TBL] [Abstract][Full Text] [Related]
10. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling, simulation and docking study of ebola virus glycoprotein.
Ahmad N; Farman A; Badshah SL; Ur Rahman A; Ur Rashid H; Khan K
J Mol Graph Model; 2017 Mar; 72():266-271. PubMed ID: 28160722
[TBL] [Abstract][Full Text] [Related]
12. Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products.
Hayat M; Gao T; Cao Y; Rafiq M; Zhuo L; Li YZ
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927063
[TBL] [Abstract][Full Text] [Related]
13. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
14. Strategies in Medicinal Chemistry to Discover New Hit Compounds against Ebola Virus: Challenges and Perspectives in Drug Discovery.
Dos Santos Nascimento IJ; da Silva Santos-Júnior PF; de Araújo-Júnior JX; da Silva-Júnior EF
Mini Rev Med Chem; 2022; 22(22):2896-2924. PubMed ID: 35379146
[TBL] [Abstract][Full Text] [Related]
15. Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors.
Broni E; Ashley C; Adams J; Manu H; Aikins E; Okom M; Miller WA; Wilson MD; Kwofie SK
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047270
[TBL] [Abstract][Full Text] [Related]
16. Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.
Baker LE; Ellena JF; Handing KB; Derewenda U; Utepbergenov D; Engel DA; Derewenda ZS
Acta Crystallogr D Struct Biol; 2016 Jan; 72(Pt 1):49-58. PubMed ID: 26894534
[TBL] [Abstract][Full Text] [Related]
17. In vitro assembly of Ebola virus nucleocapsid-like complex expressed in E. coli.
Peng R; Zhu T; Oladejo BO; Musyoki AM; Cui Y; Shi Y; Wang P; Gao GF
Protein Cell; 2016 Dec; 7(12):888-898. PubMed ID: 27650953
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic Design of Peptide Neutralizer of Ebola Virus with Molecular Simulation.
Hou Q; Zhang L
Langmuir; 2020 Feb; 36(7):1813-1821. PubMed ID: 31986884
[TBL] [Abstract][Full Text] [Related]
19. Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry.
Singleton CD; Humby MS; Yi HA; Rizzo RC; Jacobs A
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092576
[TBL] [Abstract][Full Text] [Related]
20. Review of Ebola virus infections in domestic animals.
Weingartl HM; Nfon C; Kobinger G
Dev Biol (Basel); 2013; 135():211-8. PubMed ID: 23689899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
